Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.638 USD | +1.97% | -1.37% | -5.17% |
May. 17 | HC Wainwright Adjusts Kala Pharmaceuticals Price Target to $18 From $21, Maintains Buy Rating | MT |
Apr. 02 | HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KALA BIO, INC. | Other Pharmaceuticals | +1.97% | -1.37% | -5.17% | -60.30% | -97.73% | 18.34M |
- Stock Market
- Equities
- KALA Stock
- Charts KALA BIO, Inc.
- Relative Strength Chart